Affordable Access

Publisher Website

A Study on the Mechanism of Lavender in the Treatment of Insomnia Based on Network Pharmacology.

Authors
  • Wang, Yao1
  • Zou, Junbo1, 2
  • Jia, Yanzhuo1
  • Liang, Yulin1
  • Zhang, Xiaofei1, 2, 3
  • Wang, Chang-Li1, 2
  • Wang, Xiao1, 2
  • Guo, Dongyan1, 2
  • Shi, Yajun1, 2
  • Yang, Ming4
  • 1 Department of Pharmaceutics, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, P.R. China , (China)
  • 2 Department of Pharmaceutics, College of Pharmacy, The Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, P.R. China , (China)
  • 3 Jiangxi University of Traditional Chinese Medicine, Nanchang, P.R. China , (China)
  • 4 Ministry of Education, Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, P.R. China , (China)
Type
Published Article
Journal
Combinatorial chemistry & high throughput screening
Publication Date
Jan 01, 2020
Volume
23
Issue
5
Pages
419–432
Identifiers
DOI: 10.2174/1386207323666200401095008
PMID: 32233997
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The common disease of insomnia has complex and diverse clinical manifestations. Lavender represents an effective treatment of insomnia, but the molecular mechanism underlying the effectiveness of this treatment is not clear. The purpose of this study is to investigate the active components, target proteins and molecular pathways of lavender in the treatment of insomnia, thus explaining its possible mechanism. Firstly, 54 active components of lavender were identified by gas chromatography-mass spectrometry (GC-MS). The target protein of lavender was predicted by the Traditional Chinese Medicine System Pharmacological Database and Analysis Platform and the SwissTargetPredicating tool, and the target protein of insomnia was predicted by the DisGeNET and DrugBank databases. Then, the "component-target-disease" network diagram was constructed using the Cytoscape 3.7.1 software. KEGG and GO enrichments were analyzed using the R statistical language. Finally, the key target proteins were verified by collecting and verifying the target protein GEO data using the Discovery Studio 3.5 molecular docking verification software. 906 target proteins of lavender were predicted by the Traditional Chinese Medicine System Pharmacological Database and Analysis Platform and the SwissTargetPredicating tool, and 182 insomnia target proteins were predicted by the DisGeNET and DrugBank databases. The results of GO enrichment analysis showed that it included the reaction process of ammonium ion, the regulation of the membrane potential and the secretion of catecholamine, while the results of KEGG enrichment included the calcium signaling pathway, serotonin synapse, morphine addiction and many more. Finally, using the Discovery Studio3.5 molecular docking verification software, it was verified that the key target proteins are ADRB1 and HLA-DRB1. The components in the lavender essential oil include the Ethyl 2-(5-methyl-5-vinyltetrahydrofuran- 2-yl)propan-2-ylcarbonate (0.774); 5-Oxatricyclo[8.2.0.04,6]dodecane, 4,12,12-trimethyl- 9-methylene-, (1R,4R,6R,10S)-(0.147); P-Cymen-7-ol (0.063); .alpha-Humulenem (0.317); Acetic acid, hexyl ester (1.374); etc. The role lavender plays in the treatment of insomnia might be accomplished through the regulation of the key targets ADRB1 and HLA-DRB1. Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Report this publication

Statistics

Seen <100 times